细胞周期抑制剂P27^(Kip1)对乳腺癌的预后意义
摘要
P2 7Kip1属广谱CDKI家族 ,是一种细胞周期的负向调节剂 ,在细胞增殖、分化、凋亡及肿瘤的发生发展等过程中具有重要的调节作用。人类肿瘤中P2 7基因的改变极为罕见 ,但P2 7蛋白表达的改变与其生物学行为密切相关 ,近年来的诸多研究表明P2
出处
《国外医学(生理病理科学与临床分册)》
2002年第2期110-112,共3页
Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
参考文献18
-
1Polyak K, Lee MH, Erdjument BH, et al. Cloning of P27Kip1 , a cyclindependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals [J]. Cell, 1994, 78: 59-66.
-
2Chen J, Willingham T, Shuford M, et al. Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor P27Kip1 [J].J Clin Invest, 1996, 97:1983 - 1988.
-
3Lloyd RV,Jin L, Qian X, et al. Aberrant P27Kip1 expression in endocrine and other tumors [J]. Am J Pathol, 1997, 150:401-407.
-
4Kawamata N, Morosetti R, Miller CW, etal. Molecular analysis of the cyclin-dependent kinase inhibitor gene P27Kip1 in human malignancies [J]. Cmcer Res, 1995, 55: 2266-2269.
-
5Spirin KS, Simpson JF, Takeuchi S, et al. P27Kip1 mutation found in breast cancer [J]. Cancer Res, 1996, 56:2400 - 2404.
-
6Katayose Y, Kim M, Rakkar ANS, et al. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor P27 [ J ].Cancer Res, 1997,57:5441-5445.
-
7Durand B, Gao FB, Rolf M, et al. Accumulation of the cyclin-dependent kinase inhibitor P27Kip1 and the timing of oligodendrocyte differentiation [J]. EMBO J, 1997, 16: 306-317.
-
8Muto A, Kizaki M, Yamato K, et al. 1,25-dihydroxyvitamin D3 induces differentiation of retinoic acid-resistant acute promyelocytis leukemia cell line ( UF-1 ) associated with expression of P21Waf/Cip1 and P27Kip1[J]. Blood, 1999, 93: 2225-2233.
-
9Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor P27 [J]. Science, 1995, 269: 682-685.
-
10Tan P, Cady B, Wanner M, et al. The cell cycle inhibitor P27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas [J]. Cancer Res, 1997, 57:1259 - 1263.
-
1江洪,吕大同.细胞周期抑制剂p27^(kipl)与肿瘤[J].中国医学文摘(肿瘤学),2000,14(1):77-78.
-
2马振滨,郭光红,高志星.细胞周期抑制剂P27与胃癌[J].滨州医学院学报,2005,28(3):196-198. 被引量:4
-
3孙燕,姜藻.胃癌分子靶向治疗的现状及研究进展[J].东南大学学报(医学版),2013,32(2):235-238. 被引量:9
-
4李建国,邢桂滨,宋海彬,常得丰.乳腺癌中ErbB2过表达与血管内皮生长因子A,C和D高表达的关系[J].中国伤残医学,2013,21(7):36-37.
-
5李宏伟,黄勇,谷化平.大肠癌组织中CD44v6、Ki-67蛋白表达及其生物学意义[J].实用医学杂志,2006,22(11):1261-1262. 被引量:2
-
6钱玉洁,黄昕琼,申良方.骨桥蛋白和E-钙粘素与宫颈癌放疗抵抗的相关性[J].中国现代医学杂志,2015,25(16):24-31. 被引量:6
-
7吴广宇,叶盛,郑伟明,诸葛启钏,瞿宣兴.侧脑室脑膜瘤的显微外科治疗(附12例报告)[J].医师进修杂志,2003,26(3):25-26. 被引量:4
-
8任伟,禹立霞,钱晓萍,邹征云,刘宝瑞.胃癌患者血清VEGF、MMP-2的表达及其与浸润和转移的关系[J].肿瘤学杂志,2008,14(10):824-826. 被引量:11
-
9刘睿,顾谦群,崔承彬.来源于天然产物的细胞周期抑制剂[J].天然产物研究与开发,2003,15(3):251-254. 被引量:7
-
10段伊帆,李子俊.消化系肿瘤的分子靶向治疗研究进展[J].国际消化病杂志,2012,32(2):110-113.